Ezra Launches 3T MRI/CT Combination for Full-Body Scans
The Ezra Blueprint scan reportedly includes quantitative brain measurements, coronary calcium scoring (CAC) and a full-body MRI that provides screening for over 500 conditions.
Offering a combination of 3T magnetic resonance imaging (MRI) and computed tomography (CT) that can provide fatty liver assessment, lung cancer screening and aneurysm detection with two hour-long appointments, Ezra has launched the Ezra Blueprint scan.
The Ezra Blueprint scan reportedly includes neurodegenerative assessment with brain MRI, artificial intelligence (AI)-powered quantification of subcutaneous fat and MRI angiography for possible diagnosis of brain aneurysm and carotid artery disease, according to Ezra, the developer of the Ezra Blueprint.
The newly launched Ezra Blueprint scan reportedly combines 3T MRI and CT for full-body scanning that facilitates screening for over 500 conditions. (Images courtesy of Ezra.)
Other features included in the Ezra Blueprint are high-resolution imaging of knee and hip joints, CT-based coronary calcium scoring (CAC) and full-body MRI that enables screening of over 500 conditions, according to Ezra.
After two 60-minute appointments to complete Ezra Blueprint scanning, Ezra said patients will subsequently receive a detailed radiology report and a consultation review by medical providers associated with Ezra.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
